Orbital Inflammatory Disease Diagnosis and Treatment

Definition and Classification

The American College of Radiology suggests that orbital inflammatory disease (OID) encompasses idiopathic orbital inflammatory syndrome (IOIS), IgG4-related orbital disease, and specific structure involvement, which may present with signs and symptoms mimicking infection 1, 2
IgG4-related orbital disease is a relatively recently described inflammatory condition that may account for a significant percentage of patients previously described as having idiopathic disease 1
Cellulitis is a type of specific structure involvement in OID 2

CT of the orbits with contrast is often the initial imaging modality in emergent settings, superior for foreign body assessment, calcification detection, and osseous evaluation 1, 2, 3
MRI of the orbits without and with contrast is complementary to CT, particularly valuable for evaluating suspected intracranial extension, soft-tissue characterization, and detecting fibrosis 1, 2, 3, 4
CTA or MRA may be added if vascular invasion or cavernous sinus thrombosis is suspected 3, 4

A multidisciplinary approach involving endocrinologic, neurologic, and ophthalmologic evaluation is necessary for the diagnosis and management of OID 5, 6
Biopsy may be necessary for definitive diagnosis, especially to rule out neoplastic processes like lymphoma 5, 6

The American College of Radiology recommends corticosteroids as the first-line treatment for non-infectious orbital inflammatory disease, with immunosuppressive agents reserved for steroid-resistant or recurrent cases 5, 6
Methotrexate and mycophenolate mofetil are immunosuppressive agents used for steroid-resistant cases or to reduce steroid dependence 1
Rituximab is a biological agent used for refractory cases, particularly effective for IgG4-related disease 2

Biopsy is often necessary for definitive diagnosis to rule out malignancy 5, 6
Surgical decompression is reserved for cases with optic nerve compression, severe proptosis, or failure of medical management 1, 4

Elevated serum IgG4 levels and tissue biopsy showing IgG4-positive plasma cell infiltration are necessary for diagnosis 1, 2

Sclerosing orbital inflammation is more resistant to conventional therapy and often requires more aggressive immunosuppression 4

Regular ophthalmologic examinations and repeat imaging are necessary to monitor treatment response and disease progression 1, 3